ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626760 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626760; 2) Community: the network communities that were significantly associated with the response to NSC 626760; 3) Molecule: the relationships between components within communities and NSC 626760; 4) MDR: the compounds that were significantly associated with the NSC 626760.

NSC Compound Enrichment Correlation
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0342636096654271 0.078348389
NSC 333054 Adriamycin, tetrahydropyranyl 0.0342636096654271 0.15703762
NSC 34533 Fulcin 0.0342636096654271 0.2540233
NSC 347217 Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride 0.0342636096654271 0.076947115
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0342636096654271 0.17195057
NSC 400938 Null 0.0342636096654271 0.38433987
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.0342636096654271 -0.12546451
NSC 610456 Camptothecin Derivative 0.0342636096654271 0.0297077
NSC 617582 Null 0.0342636096654271 0.14882704
NSC 617743 Pyridinium, 4-(4-methoxyphenyl)-1-(4-methylphenyl)- 2,6-diphenyl-, tetrafluoroborate(1-) 0.0342636096654271 0.21130529
Total:112  Current:73    [First] [Prev] [Next] [Last]